Conference Coverage

Bleeding episodes more common in boys with VWD


 

REPORTING FROM THSNA 2018


Multivariate regression analysis revealed independent associations between the following patient characteristics and ever having a bleed among children with type 1 VWD: male gender (adjusted odds ratio, 1.23); being aged 7-9 years at registration, compared with being aged 2-6 years (aOR, 1.5); being black (aOR, 1.7); being Asian, Native Hawaiian or Pacific Islander (aOR, 2.4), being Hispanic (aOR, 2.8), and being some other race/ethnicity (aOR, 1.8). However, family history of a bleeding disorder was protective (aOR, 0.721).

Dr. Abe said she hopes that the findings will raise awareness and help physicians to educate families about bleeding symptoms and intervene to treat bleeding episodes appropriately. She and her associates are planning to compare the data with Community Counts, “so it’s more up to date,” she said.

Dr. Abe reported having no financial disclosures.

SOURCE: Abe K et al. THSNA 2018, Poster 145.

Pages

Recommended Reading

Gene therapy for hemophilia A gets fast-track review
MDedge Hematology and Oncology
States strive to curb costs for a crucial – but exorbitant – hemophilia treatment
MDedge Hematology and Oncology
Hemophilia A treatment gains approval in Europe
MDedge Hematology and Oncology
Of ‘miracles’ and money: Why hemophilia drugs are so expensive
MDedge Hematology and Oncology
PK dosing software available in US
MDedge Hematology and Oncology
EC approves emicizumab for hemophilia A with inhibitors
MDedge Hematology and Oncology
Team creates device to study hemostasis
MDedge Hematology and Oncology
Product seems effective for ITI in severe hemophilia A
MDedge Hematology and Oncology
Product increases FIX levels in hemophilia B
MDedge Hematology and Oncology
Factor IX product launched in US
MDedge Hematology and Oncology